Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The opportunities in these indications can be assessed by deploying effective new product planning / opportunity assessment methodologies, including evaluating the following for each potential indication: Level of in-class / competitive activity Likelihood of technical and regulatory success (i.e., based on scientific rationale and regulatory precedent) Level and nature of unmet needs for new therapies in the disease area of interest Potential for GLP1-s to address these unmet needs Commercial attractiveness of market Potential speed to market Alignment with individual manufacturer portfolio / strategy / capabilities Conclusion Incretin mimetics have had an immense and growing impact on patient outcomes
Temperature Monitoring: Visibility from Start to Finish Even the best thermal packaging cant guarantee success without real-time temperature data
Will they be affordable and covered by insurance
RuY and RoY checked the content of the manuscript
*Altern Ther Health Med.* 27(S1):8-13
